ICGEB Arturo Falaschi SMART Fellowships
SMART Fellowships are intended to promote collaboration among researchers in ICGEB Member Countries. Mobility support to laboratories located in Italy, India and South Africa can be considered under exceptional circumstances and only if the research activity proposed is not covered by one of the ICGEB laboratories in Trieste, New Delhi or Cape Town.
Quality Control, Quality Assurance Jobs at Ajanta Pharma - MPharm, BPharm, MSc Apply
Process check & sampling during manufacturing and packaging. Review filled Batch manufacturing & batch packing record.
Walk In Drive for MPharm, BPharm, MSc in QA and QC at Lupin
B.Pharma/M.Pharm walkin at Lupin pharma. Experience specific of QAMS, Handled software for QMS change control, Regulatory expectations/Validation, Qualification equipment / utilities / software Investigation
Walk in Drive for MPharm, MSc, BPharm in QA, ADL, FD Department at APDM Pharma
Development of simple and complex parenteral & ophthalmic formulations - Generic & 505(B)(2), Conduct literature research and evaluate new technologies / excipients.
Walk in for Production, Stores, EHS at SMS Pharmaceuticals
Handling of Reactors, Centrifuges, Driers & Good Documentation, and Good safety Practices.
IQVIA Require Clinical Data Specialist
Serve as a Data Operations Coordinator for one protocol with less then 5 operations staff or 15+ easy to moderately complex central laboratory studies.
Lonza Posts Strong FY2025 Results, Forecasts 11–12% Sales Growth in 2026
Swiss contract development and manufacturing organization Lonza Group AG reported strong full-year results for 2025 and outlined its growth expectations for 2026.
Centre proposes Mandatory Blue Line on Labels of Antimicrobial Medicines

The Union Ministry of Health and Family Welfare has released a draft notification proposing a distinct blue vertical line on the labels of all antimicrobial medicines, a move aimed at improving identification and promoting the rational use of antibiotics in the country.

CDSCO eases Test Licence Pathway, cuts approval timelines under NDCT Rules Amendment 2026

In a move aimed at accelerating drug development while maintaining regulatory oversight, India’s drug regulator has notified sweeping changes to the New Drugs and Clinical Trials (NDCT) Rules, 2019, introducing a faster “prior intimation” route for select test licences and sharply reducing approval timelines.

The amendments, notified on January 20, 2026, under G.S.R. 46(E), mark a significant shift in how manufacturers can produce new drugs and investigational products for clinical trials, bioavailability, bioequivalence studies, and analytical testing

Pharmacy graduates can start project work at the College of Veterinary Science and Animal Husbandry
BPharm or equivalent / Bachelors Degree in Sciences OR MVSc / Masters Degree in Sciences from a recognized University or equivalent.